A Prospective, Multicenter, Single Group, Open-label and Observational Study to Evaluate the Effectiveness and Safety of Dong-A Opalmon® Tablet in Patients With Acquired Lumbar Spinal Stenosis
Latest Information Update: 31 Oct 2024
At a glance
- Drugs Limaprost (Primary)
- Indications Spinal stenosis
- Focus Therapeutic Use
- Sponsors Dong-A ST
- 29 Oct 2024 New trial record